Natalia Merker

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study

Tobias Boch, Oliver A. Cornely, Jörg Janne Vehreschild et al. · Clinical Microbiology and Infection · 2016 · 103 citations · Full text

Diagnostic Mycology, Molecular Diagnostic Techniques, Antifungal Agent +10

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the<i>Aspergillus fumigatus cyp51A</i>Gene in Primary Clinical Samples from Neutropenic Patients

Wolfgang Seifarth, Natalia Merker, Susan J. Howard et al. · Antimicrobial Agents and Chemotherapy · 2012 · 57 citations · Full text

Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013

Patricia Postina, Mark Reinwald, Oliver A. Cornely et al. · PLoS ONE · 2014 · 49 citations · Full text

Diagnostic Mycology, Immunodeficiencies, Pathology +17

Identification of invasive fungal diseases in immunocompromised patients by combining an <i>Aspergillus</i> specific <scp>PCR</scp> with a multifungal <scp>DNA</scp>‐microarray from primary clinical samples

Tobias Boch, Mark Reinwald, Patricia Postina et al. · Mycoses · 2015 · 39 citations

Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients

Patricia Postina, Julian Skladny, Tobias Boch et al. · Frontiers in Microbiology · 2018 · 26 citations · Full text